What sets this conference apart is its focus on regulatory case studies. With regulatory frameworks still under construction, researchers and developers will share their journeys, real-world experiences that become practical case studies for the entire community. These insights are not only about presenting science, but about turning individual challenges into collective knowledge.
This unique positioning is clearly reflected in the conference programme, which features sessions on biomarkers and diagnostics, One Health applications, regulatory assessment, and advances in clinical data and emerging technologies. Each theme illustrates how scientific discovery meets regulatory direction to shape the next decade of microbiome innovation.
